Oppenheimer Reiterates Outperform Rating, $16 Price Target on Milestone Pharmaceuticals (MIST), "We Like Risk/Reward into RAPID Trial Readout"

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. SPY
3. GLOB
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Oppenheimer Reiterates Outperform Rating, $16 Price Target on Milestone Pharmaceuticals (MIST), "We Like Risk/Reward into RAPID Trial Readout"
(NASDAQ: MIST) Delayed: 1.10 +0.03 (2.80%)
Previous Close $1.07    52 Week High $ 
Open $1.07    52 Week Low $ 
Day High $1.10    P/E N/A 
Day Low $1.04    EPS $ 
Volume 2,167,025